Autopsy report · NCT03603535

Prospective Study of the sensiTVT

“The recruitment proceeded much slower than expected. The planned number of patients could not be reached within the planned time.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 5 years before it stopped.
• 35 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Medical University of Graz

Sponsor type

University, hospital or other

Conditions

Stress Urinary Incontinence

Interventions

sensiTVT

Participants

35

Sites

1

Countries

Austria

Trials that died the same way

• A Trial of the Irradiance Level of Phototherapy for Neonatal Jaundice
  “it was estimated that the recruitment of the planned number of patients could not be completed within further 5 years.” (80% match in meaning)
• Rituximab in Metastatic Melanoma
  “the only reason is that recruitment was not sufficient to meet the planned patient numbers, because complete remissions are still infrequent.” (76% match in meaning)
• Bosentan for Treatment of Hepatopulmonary Syndrome in Patients With Liver Cirrhosis
  “too slow patient recruitment” (76% match in meaning)
• Growth Hormone in Poor Responders to IVF Trial
  “Insufficient/slow patient recruitment” (76% match in meaning)
• Efficacy of Rituximab in Acute Cellular Rejection in Renal Transplant Patients
  “The planned recruitment number of 180 Patient could not been achieved.” (76% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.